A study examined the potential of a prognostic tool that could better identify patients with type 1 or type 2 diabetes at risk for end stage renal disease.
Researchers examined a primary care-based telemedicine program to study diabetic retinopathy screening rates, shorten screening wait times, and reduce referrals.
In a recent systematic analysis, researchers assessed the effects of pharmacologic treatments of diabetic peripheral neuropathy on pain and quality of life.
Researchers examined the effectiveness of screening tests for diagnosing patients with prediabetes and the interventions to prevent the onset of type 2 diabetes.